The statistic showing that more than one-third of currently marketed drugs target G-protein coupled receptors is often quoted as evidence that those receptors make good drug targets. And they do. But such convergence is also evidence that although drug discovery is a vast endeavor, in some ways it could be described as a mile wide and an inch deep.